Cargando…

Age-Related microRNA Overexpression in Lafora Disease Male Mice Provides Links between Neuroinflammation and Oxidative Stress

Lafora disease is a rare, fatal form of progressive myoclonus epilepsy characterized by continuous neurodegeneration with epileptic seizures, characterized by the intracellular accumulation of aberrant polyglucosan granules called Lafora bodies. Several works have provided numerous evidence of molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romá-Mateo, Carlos, Lorente-Pozo, Sheila, Márquez-Thibaut, Lucía, Moreno-Estellés, Mireia, Garcés, Concepción, González, Daymé, Lahuerta, Marcos, Aguado, Carmen, García-Giménez, José Luis, Sanz, Pascual, Pallardó, Federico V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865572/ https://www.ncbi.nlm.nih.gov/pubmed/36674605 http://dx.doi.org/10.3390/ijms24021089

Ejemplares similares

Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model
por: Moreno-Estellés, Mireia, et al.
Publicado: (2023)

Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level
por: Romá-Mateo, Carlos, et al.
Publicado: (2011)

Lafora Disease: A Ubiquitination-Related Pathology
por: García-Gimeno, Maria Adelaida, et al.
Publicado: (2018)

Laforin, a Dual Specificity Phosphatase Involved in Lafora Disease, Is Present Mainly as Monomeric Form with Full Phosphatase Activity
por: Dukhande, Vikas V., et al.
Publicado: (2011)

Laforin, the most common protein mutated in Lafora disease, regulates autophagy
por: Aguado, Carmen, et al.
Publicado: (2010)

Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model
por: Mollá, Belén, et al.
Publicado: (2022)

Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020)

Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease
por: Sanz, Pascual, et al.
Publicado: (2021)

Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)

An empirical pipeline for personalized diagnosis of Lafora disease mutations
por: Brewer, M. Kathryn, et al.
Publicado: (2021)

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011)

A PTG Variant Contributes to a Milder Phenotype in Lafora Disease
por: Guerrero, Rosa, et al.
Publicado: (2011)

Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
por: Schokraie, Elham, et al.
Publicado: (2013)

Unusual Course of Lafora Disease
por: Zutt, Rodi, et al.
Publicado: (2016)

Increased Endoplasmic Reticulum Stress and Decreased Proteasomal Function in Lafora Disease Models Lacking the Phosphatase Laforin
por: Vernia, Santiago, et al.
Publicado: (2009)

Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism
por: Couarch, Philippe, et al.
Publicado: (2011)

Lafora Disease Masquerading as Hepatic Dysfunction
por: Inayat, Faisal, et al.
Publicado: (2018)

Lafora disease in miniature Wirehaired Dachshunds
por: Swain, Lindsay, et al.
Publicado: (2017)

Retinal alterations in patients with Lafora disease
por: Heitkotter, Heather, et al.
Publicado: (2021)

Lafora disease: a case report
por: Zeka, Naim, et al.
Publicado: (2022)

Vagus nerve stimulation in Lafora body disease()
por: Hajnsek, Sanja, et al.
Publicado: (2013)

Treatment with metformin in twelve patients with Lafora disease
por: Bisulli, Francesca, et al.
Publicado: (2019)

Lafora Disease: Report of a Rare Entity
por: Al Mufargi, Younis, et al.
Publicado: (2020)

Trehalose Treatment in Zebrafish Model of Lafora Disease
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models
por: Gumusgoz, Emrah, et al.
Publicado: (2022)

Comparative Analysis of Chromatin-Delivered Biomarkers in the Monitoring of Sepsis and Septic Shock: A Pilot Study
por: Beltrán-García, Jesús, et al.
Publicado: (2021)

Small RNA-seq analysis of circulating miRNAs to identify phenotypic variability in Friedreich’s ataxia patients
por: Seco-Cervera, Marta, et al.
Publicado: (2018)

The Laforin–Malin Complex, Involved in Lafora Disease, Promotes the Incorporation of K63-linked Ubiquitin Chains into AMP-activated Protein Kinase β Subunits
por: Moreno, Daniel, et al.
Publicado: (2010)

Genetics of Lafora progressive myoclonic epilepsy: current perspectives
por: Kecmanović, Miljana, et al.
Publicado: (2016)

Extraneurological sparing in long‐lived typical Lafora disease
por: Goldsmith, Danielle, et al.
Publicado: (2018)

Genotypes and phenotypes of patients with Lafora disease living in Germany
por: Brenner, David, et al.
Publicado: (2019)

Canine Lafora Disease: An Unstable Repeat Expansion Disorder
por: von Klopmann, Thilo, et al.
Publicado: (2021)

Glial Contributions to Lafora Disease: A Systematic Review
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Retinal Phenotyping of a Murine Model of Lafora Disease
por: Vincent, Ajoy, et al.
Publicado: (2023)

Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease
por: Ortolano, Saida, et al.
Publicado: (2014)

Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel
por: Dirani, Maya, et al.
Publicado: (2014)

Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
por: Sullivan, Mitchell A., et al.
Publicado: (2017)

Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease
por: Burgos, Daniel F., et al.
Publicado: (2020)

Malin restoration as proof of concept for gene therapy for Lafora disease
por: Varea, Olga, et al.
Publicado: (2022)

Electro-clinical features and management of the late stage of Lafora disease
por: d'Orsi, Giuseppe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ko296i313bfto0u8927a7heoa